Aspen to produce COVID-19 vaccine in Africa
“A deal struck by South Africa’s Aspen Pharmacare to manufacture COVID-19 vaccine in Port Elizabeth will bring technology transfer but may not increase the supply of vaccines to the continent.”
You might also like
More analysis from COVID-19 Africa Watch:
- Interview with Megan McDonald: COVID-19, African Capital Markets, and What Lies Ahead
- Interview: CBK Governor Dr. Patrick Njoroge on Kenya’s Priorities for Economic Resilience and Sustainability
- Strive Masiyiwa: “How can I say science has delivered a miracle to people who are dying?”
- A Global Warning System: Mobilizing Surveillance for Emerging Pathogens
COVID-19 Africa Watch tracks major developments and policy announcements from across the continent and also offers a curated selection of analysis on how the pandemic will impact African economies and development efforts. The site is a project of the Milken Institute’s Global Market Development Practice.
Share:
A hub for information, analysis, and the global response to COVID-19’s impact on Africa